NYSE:AGN

193.02
0.00 (0.00%) 1d
0

Related posts

Top 4 BNN Stock Picks to Buy this Summer
COMMENT
Allergan PLC.
The aesthetics business of this Botox maker account for over 40% of company revenues and this the top player in the business. They also have clinical drugs for application like urinary, psychiatric and migraines.
Consumer Products
HOLD
Allergan PLC.
Hold onto this stock. Even though the balance sheet is not great, there is a good chance their aggressive earnings outlook will drag the stock back up. It is extremely cheap at these levels.
Consumer Products
PAST TOP PICK
Allergan PLC.
(A Top Pick Dec 15/18, Down 8%) He sold in the $1.90 range. There is talk of them spinning out their cosmetic division but it has not happened yet. He could get back into it. He was unfortunate trading this.
Consumer Products
PAST TOP PICK
Allergan PLC.

(A Top Pick September 14/17- Down 22%.) This was a high-risk position. They sold a drug to a native band and then they leased the rights back to circumvent potential generic competition. Something cheeky and probably that is why the stock sold off. Their strength is still in Botox and aesthetics. He doesn’t see that changing or being threat. He still likes it. Management is under the gun.

Consumer Products
DON'T BUY
Allergan PLC.

Form a valuation standpoint, trading at 10 times forward earnings with high single digit growth rate. But the stock keeps falling down. He would be very careful with this. Could be a value trap.

Consumer Products
TOP PICK
Allergan PLC.

They are the maker of Botox. They have a drug for dry eye syndrome that will come off patent but his analysis of the case for losing all revenue from the drug has them still doing well. They have a good drug pipeline. (Analysts’ target: $225.00).

Consumer Products
SELL
Allergan PLC.

Their number 1 product is Botox and their number 2 product is eye drops, and there is some competition coming from generics for their eyedrops drug. Thinks that is what has been hurting the stock recently. When the technicals are working against you where a stock has fallen below the 200-day moving average, and the price is below both the 50 day and 100 day, technically you want to step away.

Consumer Products
SELL
Allergan PLC.

(Market Call Minute.) A broken stock and he would Sell it and move on.

Consumer Products
DON'T BUY
Allergan PLC.

We are in a structural bull market for equities. We are skating through the two toughest months of the year without much volatility. Don’t buy a company that has been put into the penalty box. Stocks that have broken down have an army of people who just want to get their money back.

Consumer Products
TOP PICK
Allergan PLC.

They are known for Botox. Aesthetics is a big part of their business as well as a great urology business and Gastro Intestinal business. They sold their urology business and reinvested their cash into R&D. It is very inexpensive. (Analysts’ target: $271.50).

Consumer Products
COMMENT
Allergan PLC.

This has things like Botox, etc., but also have some things on the pharmaceutical side. He felt that they had a great quarter. Made 10 acquisitions in the past year with the proceeds of the generics they sold to Teva. Trading around 13X forward earnings, so not terribly expensive. He likes this one.

Consumer Products
COMMENT
Allergan PLC.

He likes the pharmaceuticals. They are under a bit of pressure from legislation on repricing, but thinks most of that is priced in. He would say “yes” for this one.

Consumer Products
PAST TOP PICK
Allergan PLC.

(Top Pick Nov 29/16, Up 28.87%) He still likes it despite the return. They are very diligent at returning to shareholders. They have been making strategic acquisitions and their pipeline is full. He continues to like it.

Consumer Products
PAST TOP PICK
Allergan PLC.

(A Top Pick Aug 17/16. Down 13.44%.) A terrific company, and shows up as the highest quality company in its group. Unfortunately, they got painted by the specialty pharmaceutical brush. It is getting a bit of a reprieve right now. He still likes this. It has one of the best growth profiles of any of the specialty pharmaceutical companies. The majority of its businesses are not subject to the same type of price controls that could come under government scrutiny.

Consumer Products
COMMENT
Allergan PLC.

United Therapeutic (UTHR-Q) or Allergan (AGN-N)? This is a tough one because they are 2 very different companies. Of the 2, this is a much larger company and more broadly-based.

Consumer Products
Showing 1 to 15 of 44 entries

Allergan PLC.(AGN-N) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Allergan PLC. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Allergan PLC.(AGN-N) Frequently Asked Questions

What is Allergan PLC. stock symbol?

Allergan PLC. is a American stock, trading under the symbol AGN-N on the New York Stock Exchange (AGN). It is usually referred to as NYSE:AGN or AGN-N

Is Allergan PLC. a buy or a sell?

In the last year, there was no coverage of Allergan PLC. published on Stockchase.

Is Allergan PLC. a good investment or a top pick?

Allergan PLC. was recommended as a Top Pick by on . Read the latest stock experts ratings for Allergan PLC..

Why is Allergan PLC. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Allergan PLC. worth watching?

0 stock analysts on Stockchase covered Allergan PLC. In the last year. It is a trending stock that is worth watching.

What is Allergan PLC. stock price?

On 2020-05-08, Allergan PLC. (AGN-N) stock closed at a price of $193.02.